secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sonoma Pharmaceuticals, Inc. (SNOA)
CIK:        0001367083
Form:       8-K
Filed at:   2024-04-02T23:59:59+00:00
Accession:  0001683168-24-002051
Event type: other
Sentiment:  neutral
Materiality: 0.05
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sonoma Pharmaceuticals updates investor presentation; no material changes
-------------------------------------------------------------------------

- HOCl product portfolio covers wound, eye, oral, nasal, dermatology, podiatry, and animal health
- Products sold in 55 countries via direct sales and distribution partners
- No new financial guidance or material business developments in the presentation

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1367083/000168316824002051/0001683168-24-002051-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1367083/000168316824002051/sonoma_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-24-002051

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer